BioScrip Management Discusses Q2 2012 Results - Earnings Call Transcript

BioScrip (BIOS)

Q2 2012 Earnings Call

August 09, 2012 9:00 am ET

Executives

Lisa Wilson

Richard M. Smith - Chief Executive Officer, President, Chief Operating Officer and Director

Hai V. Tran - Chief Financial Officer, Senior Vice President and Treasurer

Analysts

Brooks G. O'Neil - Dougherty & Company LLC, Research Division

Michael John Petusky - Noble Financial Group, Inc., Research Division

Presentation

Operator

Compare to:
Previous Statements by BIOS
» BioScrip's CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
» BioScrip's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» BioScrip's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Ladies and gentlemen, thank you for standing by. Welcome to the BioScrip Second Quarter Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded, Thursday, August 9, 2012.

I would now like to turn the conference over to Lisa Wilson, Investor Relations with BioScrip. Please go ahead

Lisa Wilson

Good morning, and thank you for joining us today. By now you should have received a copy of our press release issued yesterday after the close of market. If you've not received it, you may access it through the Investor Relations section at our website. Rick Smith, President and Chief Executive Officer and Hai Tran, Chief Financial Officer, will host this morning's call.

The call may be accessed through our website at bioscrip.com. A replay will be available shortly after the call's completion. Interested parties can access the replay by dialing [phone] in the U.S. and [phone] internationally and entering access code 21600696. An audio webcast will also be available for 30 days following the call under the Investor Relations section of the BioScrip website at bioscrip.com.

Before we get started, I would like to remind everyone that any forward-looking statements made during the call are protected under the Safe Harbor of the Private Securities Litigation and Reform Act. Such forward-looking statements are based upon current expectations, and there can be no assurance that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to a number of important factors and risks, which are identified in our press release and our annual and quarterly reports filed with the SEC. These forward-looking statements are based on information available to BioScrip today, and the company assumes no obligation to update statements as circumstance change.

1 2 3 Next › Last »